[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pharmather Hldgs Ltd (PHRRF)

Pharmather Hldgs Ltd (PHRRF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0411 +20.68%
on 05/14/26
0.0968 -48.76%
on 04/22/26
+0.0030 (+6.44%)
since 04/15/26
3-Month
0.0388 +27.84%
on 04/06/26
0.0968 -48.76%
on 04/22/26
-0.0122 (-19.74%)
since 02/13/26
52-Week
0.0388 +27.84%
on 04/06/26
0.5500 -90.98%
on 08/11/25
-0.1229 (-71.25%)
since 05/15/25

Most Recent Stories

More News
PharmaTher's Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus

Independent research identified cepharanthine as a potential Hantavirus entry inhibitor, supporting further evaluation of Sairiyo's patented, orally bioavailable PD-001 cepharanthine formulation for HantavirusToronto,...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0496 (-1.78%)
PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness

Company believes supportive U.S. policy momentum may strengthen the strategic value of its ketamine patch, KetaVaultâ„¢ platform, retained ketamine programs, and prior FDA-approved ketamine ANDA transactionToronto,...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0496 (-1.78%)
PharmaTher's Microneedle Patch Platforms Positioned to Benefit from Major U.S. Catalysts in Psychedelics and Peptides

U.S. regulatory momentum in psychedelics and peptides could open new commercial opportunities for PharmaTher's PatchPrintâ„¢ automated manufacturing platform and PharmaPatchâ„¢ product platform as an attractive...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0496 (-1.78%)
PharmaTher Supports Proposed U.S. Peptide Reclassification, Reinforcing the Strategic Value of Its Microneedle Patch Platforms for Peptide Delivery

Anticipated peptide reclassification could expand the addressable market for PharmaTher's PharmaPatchâ„¢ product strategy and PatchPrintâ„¢ manufacturing platform, strengthening its position in next-generation...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0496 (-1.78%)
PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology

Patent filing intended to strengthen PharmaTher's peptide formulation capabilities for PharmaPatchâ„¢ while complementing PatchPrintâ„¢ as part of the Company's broader microneedle patch development and...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0496 (-1.78%)
PharmaTher Introduces PatchPrint(TM) With Provisional Patent Filing and Commercialization Strategy for Microneedle Patches

Leveraging its PharmaPatchâ„¢ experience, the Company is introducing PatchPrintâ„¢ to support existing microneedle patch programs and expand into on-demand personalized patch solutions, including peptide...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0496 (-1.78%)
PharmaTher Expands PharmaPatch Delivery Platform into Therapeutic Peptides for the U.S. Market

Toronto, Ontario--(Newsfile Corp. - March 3, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the therapeutic...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0496 (-1.78%)
PharmaTher Launches Strategic Initiative to Pursue Health Canada Approval for Generic Semaglutide in Canada, Building on FDA-Approved Ketamine Success

Toronto, Ontario--(Newsfile Corp. - February 2, 2026) - PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) (the "Company" or "PharmaTher"), a specialty pharmaceutical company, today announced a new strategic...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0496 (-1.78%)
PharmaTher Expands PharmaPatch(TM) Platform into GLP-1 for Obesity, Leveraging Its Ketamine and Psychedelic Patch Programs

Toronto, Ontario--(Newsfile Corp. - January 14, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0496 (-1.78%)
PharmaTher CEO Publishes Letter to Shareholders

Toronto, Ontario--(Newsfile Corp. - January 2, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher") today announced that CEO Fabio Chianelli has published a letter...

PHRM.CN : 0.0650 (unch)
PHRRF : 0.0496 (-1.78%)

Key Turning Points

3rd Resistance Point 0.0612
2nd Resistance Point 0.0581
1st Resistance Point 0.0538
Last Price 0.0496
1st Support Level 0.0464
2nd Support Level 0.0433
3rd Support Level 0.0390

See More

52-Week High 0.5500
Fibonacci 61.8% 0.3547
Fibonacci 50% 0.2944
Fibonacci 38.2% 0.2341
Last Price 0.0496
52-Week Low 0.0388

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.